Advertisement
Screener

Beyond Air, Inc. (XAIR) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

2.3 / 5 stars · 23/49 Roast Me

Beyond Air, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Beyond Air, Inc. (XAIR) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $12.92 million for the 12-month period ending 2022-03-31, per its 10-K filed 2022-06-29.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets

us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-06-29

  • Beyond Air, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $12.92M.
  • Beyond Air, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $6.68M.
Period endValuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 monthValuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed
2022-03-31$12.92M
10-K · filed 2022-06-29
2020-03-31$6.68M
10-K · filed 2021-06-10
$6.17M
10-K · filed 2020-06-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B